Huamai Tyco

Beijing, China Founded: 2011 • Age: 15 yrs
Abdominal aortic stent systems are developed for disease treatment.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding $14.0M 1 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Huamai Tyco

Huamai Tyco is a company based in Beijing (China) founded in 2011 by Jian Zhou. Huamai Tyco has raised $14 million across 1 funding round from investors including General Technology Venture Capital, Everest Ventures Group and Insight Capital. Huamai Tyco operates in a competitive market with competitors including SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others.

  • Headquarter Beijing, China
  • Founders Jian Zhou
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $14 M (USD)

    in 1 rounds

  • Latest Funding Round
    $14 M (USD), Series B

    Jul 01, 2019

  • Investors
    General Technology Venture Capital

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Huamai Tyco

Huamai Tyco has successfully raised a total of $14M through 1 strategic funding round. The most recent funding activity was a Series B round of $14 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $14.0M
  • First Round

    (01 Jul 2019)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2019 Amount Series B - Huamai Tyco Valuation General Technology Venture Capital
Everest Ventures Group , Insight Capital

Investors in Huamai Tyco

Huamai Tyco has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include General Technology Venture Capital, Everest Ventures Group and Insight Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
General Technology Venture Capital
-
Founded Year Domain Location
Everest Ventures Group
Fin-tech startups are incubated by the Hong Kong-based studio.
Founded Year Domain Location
Insight Capital
Multiple sectors are invested in by the venture capital firm.
Founded Year Domain Location

Investments & Acquisitions by Huamai Tyco

Investments

Financial Statements - Huamai Tyco

Huamai Tyco Comparisons

+
Add Comparison
Available on Premium

Competitors of Huamai Tyco

Huamai Tyco operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others.

Company Name Domain Founded year HQ Location Description
SMT
domain founded_year HQ Location
SMT is recognized as a developer of cardiovascular medical devices.
InspireMD
domain founded_year HQ Location
Proprietary stent systems with bio-stable mesh are developed and commercialized.
Vesper Medical
domain founded_year HQ Location
Venous stent system is developed for deep vein disease treatment.
Endospan
domain founded_year HQ Location
Endovascular stent graft systems for aortic aneurysm repair are developed.
Biosensors International
domain founded_year HQ Location
Products for interventional cardiology and critical care procedures
Veryan Medical
domain founded_year HQ Location
Three-dimensional vascular stents for peripheral vascular disease are developed.

Latest news on Huamai Tyco

Frequently Asked Questions about Huamai Tyco

Huamai Tyco was founded in 2011 and raised its 1st funding round 8 years after it was founded.

Huamai Tyco is headquartered in Beijing, China.

Jian Zhou is the current CEO of Huamai Tyco. They have also founded this company.

Huamai Tyco is a funded company, having raised a total of $14M across 1 funding round to date. The company's 1st funding round was a Series B of $14M, raised on Jul 01, 2019.

Founded in 2011 and based in Beijing, China, the company operates in the medical device sector. An abdominal aortic covering stent system is provided for treating aortic diseases. The system is composed of a main body stent graft, a conveyor, and a leg-mounted stent graft. Development and production activities are centered on these components to address vascular conditions.

Huamai Tyco's top competitors include SMT, InspireMD and Endospan.

Huamai Tyco has 3 investors. Key investors include General Technology Venture Capital, Everest Ventures Group, and Insight Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available